Delivery Order SPE2DB24D2101-SPE2DB25FKPMK
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,494.65 firm fixed price contract is for the supply of KENGREAL 50 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of July 15, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the...
- This federal contract award, with ID SPE2DB22D3301|SPE2DB24FX8UB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Firm Fixed Price Delivery Order, has a ceiling value of $7,700.47 and an ultimate completion date of January 17, 2024. The contract is for the supply of KENGREAL 50 MG VIALS, a pharmaceutical product, to support federal healthcare programs. AmerisourceBergen...
- This federal contract award, valued at $12,389.69, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KENGREAL 50 MG VIALS, a medical product, and is a Firm Fixed Price Delivery Order with a completion date of February 19, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This is a $6,207.65 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of KENGREAL 50 MG VIALS, a specialized cardiovascular medication. The contract has an ultimate completion date of December 26, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
- <p>The Defense Logistics Agency awarded a $43,248 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562100543 KENGREAL 50 MG VIALS. To be performed in Conshohocken, Pennsylvania from September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order supports DLA's logistical requirements for specified drug products. No subcontractors or set aside designations were indicated.</p>
- This federal contract award, valued at $43,389.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KENGREAL 50 MG VIALS, a medical product used in cardiovascular treatment. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Kerendia 10 mg tablets in a quantity of 30 units. This firm fixed-price delivery order, valued at $6,857.16, was competitively awarded with no set-aside designation and is scheduled for completion by August 12, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $47,741.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Kerendia 10 mg tablets (30-count packages). The delivery order, which is unclassified as a set-aside contract, is scheduled for completion by September 4, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract issued under AmerisourceBergen Drug Corp's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Kerendia 10 mg tablets (30-count packages) with a ceiling value of $1,529.00. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $5,954.02 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPMKDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Kengreal 50 mg vials, a pharmaceutical product used in acute coronary syndrome treatment. This firm fixed-price delivery order, valued at $5,673.24, is scheduled for completion by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen serves military and veteran healthcare systems with an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. The parent IDC provides a comprehensive global pharmaceutical support vehicle enabling flexible fulfillment of medical procurement across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 9/12/25 |